These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8929236)

  • 1. Pharmacokinetics of some new oral blood glucose-lowering agents in dogs.
    Heitzmann T; Neidlein R; Freund P; Reiff K; Strein K
    Arzneimittelforschung; 1995 Nov; 45(11):1182-7. PubMed ID: 8929236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
    Heitzmann T; Neidlein R; Freund P; Reiff K; Strein K
    Arzneimittelforschung; 1995 Dec; 45(12):1284-8. PubMed ID: 8595085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the new oral blood glucose-lowering agent (-)-2-(4-tert.-butylphenoxy)-7-(4-chlorophenyl)-heptanic acid sodium salt in mice, rats and dogs.
    Heitzmann T; Neidlein R; Freund P; Strein K
    Arzneimittelforschung; 1995 Aug; 45(8):868-72. PubMed ID: 7575749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
    Jajoo HK; Mamidi RN; Vakkalanka SV; Sathyavageeswaran S; Katneni K; Ayalasomayajula PS; Rao BP; Lohray BB; Subramaniam S
    Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs.
    Plum A; Agerso H; Andersen L
    Drug Metab Dispos; 2000 Feb; 28(2):155-60. PubMed ID: 10640512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs.
    Al-Azzam SI; Fleckenstein L; Cheng KJ; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2007 Nov; 28(8):431-8. PubMed ID: 17847063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies.
    Porta V; Schramm SG; Kano EK; Koono EE; Armando YP; Fukuda K; Serra CH
    J Pharm Biomed Anal; 2008 Jan; 46(1):143-7. PubMed ID: 18031967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the organic nitrates trans-N-(4-nitroxycyclohexyl)-urea in dogs and trans-N-(4-nitroxycyclohexyl)-acetamide in dogs and in man.
    Zell C; Neidlein R; Strein K; Bartsch W; Michel H
    Arzneimittelforschung; 1994 Nov; 44(11):1186-90. PubMed ID: 7848329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of fosfosal in rats and dogs.
    Ramis J; Mis R; Forn J
    Arzneimittelforschung; 1989 Jan; 39(1):74-7. PubMed ID: 2719746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple and extractionless high-performance liquid chromatographic determination of rosiglitazone in human plasma and application to pharmacokinetics in humans.
    Kim KA; Park JY
    Biomed Chromatogr; 2004 Oct; 18(8):613-5. PubMed ID: 15386508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of nateglinide in humans.
    Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.